Broviac 0600544Recalls & reported problems
Bard Access Systems, Inc. · Broviac 6.6 Fr Single-Lumen CV Catheter Peel-Apart Introducer Kit with SureCuff · Class 2 · Implant
All models of Broviac (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00801741051838), received between Apr 19, 2017 and Dec 9, 2024 — classified as 3 injuries, 5 malfunctions.
The most frequently reported specific device problem is “Fracture” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Fracture4
- Break2
- Adverse Event Without Identified Device or Use Problem1
- Air Leak1
- Burst Container or Vessel1
- Failure to Infuse1
- Malposition of Device1
- Material Protrusion/Extrusion1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Known Impact Or Consequence To Patient2
- Pulmonary Embolism2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Needle Stick/Puncture1
- No Consequences Or Impact To Patient1
- Pneumothorax1
- Venipuncture1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 9, 2024Burst Container or Vessel; Fracture; Stretched; Material Protrusion/Extrusion; Burst Container or Vessel; Fracture; Stretched; Material Protrusion/Extrusion
IT WAS REPORTED THAT APPROXIMATELY TWO YEARS POST A CHRONIC CATHETER PLACEMENT, THE CATHETER WAS ALLEGEDLY EXPLODED WHEN FLUSHED THE LINE PRIOR TO INFUSION. REPORTEDLY, THE CATHETER WAS REMOVED AND REPLACED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20875843 ↗InjurySep 22, 2021Fracture; Material Separation; Migration; Fracture; Material Separation; Migration
IT WAS REPORTED THROUGH THE LITIGATION PROCESS POST PORT PLACEMENT, THE CATHETER OF THE DEVICE ALLEGEDLY FRACTURED WITH MIGRATION OF THE FRACTURE FRAGMENT OVERLYING THE HEART. REPORTEDLY, THE FRACTURED CATHETER FRAGMENT EMBOLIZED TO THE HEART AND A SURGERY WAS PERFORMED VIA A PERCUTANEOUS PROCEDURE TO RETRIEVE THE FRAGMENT. THE PATIENT WAS REPORTED TO BE IN A STABLE CONDITION.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Pulmonary Embolism
MAUDE report 12511244 ↗MalfunctionApr 22, 2021Fracture; Fracture
IT WAS REPORTED THAT DURING A PROCEDURE, THE CATHETER WAS ALLEGEDLY FOUND TO BE BROKEN. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11705557 ↗InjuryApr 16, 2021Fracture; Failure to Infuse; Malposition of Device; Fracture; Failure to Infuse; Malposition of Device
IT WAS REPORTED THROUGH THE LITIGATION PROCESS THAT POST PORT DEVICE IMPLANT, THE PORT ALLEGEDLY MISPOSITIONED AND AS A RESULT THE LUNG WAS NOTED TO BE COLLAPSED AND PUNCTURED. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.
Patient problems: Needle Stick/Puncture; Pneumothorax; Pulmonary Embolism
MAUDE report 11676799 ↗MalfunctionApr 15, 2020Material Puncture/Hole; Material Puncture/Hole
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 0600544 CHRONIC CATHETER ALLEGEDLY EXPERIENCED MATERIAL PUNCTURE/HOLE. THIS INFORMATION WAS RECEIVED FROM ONE SOURCE. THE MALFUNCTION INVOLVED A PATIENT WITH NO KNOWN IMPACT TO THE PATIENT. THE (B)(6) YEAR OLD FEMALE PATIENT WAS (B)(6) KG.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9965321 ↗MalfunctionAug 31, 2017Break
IT WAS REPORTED BY THE FACILITY THAT THE PATIENT PRESENTED WITH A DISTAL PIN-POINT BREAK IN THE BROVIAC. THE FAMILY WAS IN (B)(6) (FOR PATIENT TO RECEIVE JOINT INJECTIONS) EARLIER IN THE DAY WHEN THE BREAKAGE WAS NOTED AND THEY DROVE TO (B)(6) FOR REPAIR.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6836328 ↗MalfunctionAug 31, 2017Air Leak; Break
IT WAS REPORTED BY THE FACILITY THAT THE PATIENT PRESENTED WITH A BROVIAC WITH A BUBBLE IN THE LINE DISTAL TO THE INSERTION SITE AND UNABLE TO USE PER PATIENT'S DAD AND NURSE IN ER. THE BUBBLE OR POSSIBLE BREAK APPEARED TO HAVE CLOSED THE EXIT SITE FOR THE REPAIR.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6836209 ↗InjuryApr 19, 2017Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED BY THE FACILITY: "GENERAL ENDOTRACHEAL ANESTHESIA WAS INDUCED. THE CHEST AND NECK WERE PREPPED AND DRAPED IN A STANDARD STERILE FASHION USING BETADINE PAINT. ACCESS ATTEMPT WAS MADE FROM THE LEFT SUBCLAVIAN POSITION. THERE WAS RETURN OF NONPULSATILE BLOOD. A WIRE WAS ADVANCED USING THE SELDINGER TECHNIQUE WITHOUT RESISTANCE. THE WIRE WAS SEEN ACROSS THE MIDLINE BY FLUOROSCOPIC GUIDANCE AND THE RIGHT BORDER OF THE HEART. IT WAS FELT TO BE SAFELY IN A VENOUS POSITION. AT THIS POINT, A COUNTER INCISION WAS MADE IN THE LEFT ANTERIOR CHEST WALL. A 0.5% BUPIVACAINE WAS INFILTRATED IN SKIN AND SUBCUTANEOUS TISSUES AT THE SITE. A 6.6 FRENCH BROVIAC CATHETER WAS TUNNELED FROM THE ANTERIOR CHEST WALL SITE TOWARDS THE VESSEL PUNCTURE SITE AND DELIVERED. IT WAS MEASURED TO APPROPRIATED SIZE AND CUT. NEXT, UNDER DIRECT FLUOROSCOPIC GUIDANCE, A 7 FRENCH PEEL AWAY SHEATH INTRODUCER WAS ADVANCED OVER THE WIRE TOWARDS THE HEART. AGAIN, IT CROSSED THE MIDLINE AND TURNED TOWARDS THE RIGHT HEART BORDER. NEXT, THE OBTURATOR FROM THE PEEL AWAY SHEATH WAS REMOVED IN ORDER TO PLACE THE CATHETER FORWARD. AT THIS TIME, WE ENCOUNTERED BRIGHT RED HIGH PRESSURE BLOODY RETURN. END RESULT WAS END
Patient problems: Venipuncture
MAUDE report 6505005 ↗
Other Catheter,intravascular,therapeutic,long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC® Catheters 1174108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall222 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page